Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Browne

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Nature Communications|November 2, 2022
Author Correction: Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland studyClaire E Hastie, David J Lowe, Andrew McAuley, et al.
Nature Communications|October 12, 2022
Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland studyClaire E Hastie, David J Lowe, Andrew McAuley, et al.
Pilot and Feasibility Studies|December 15, 2016
Reducing dementia risk by targeting modifiable risk factors in mid-life: study protocol for the Innovative Midlife Intervention for Dementia Deterrence (In-MINDD) randomised controlled feasibility trialCatherine A O'Donnell, Susan Browne, Maria Pierce, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 19, 2004
Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's diseaseRobert J Ferrante, Hoon Ryu, James K Kubilus, et al.
Chemmedchem|March 29, 2019
Discovery, Optimization, and Biological Characterization of 2,3,6-Trisubstituted Pyridine-Containing M<sub>4</sub> Positive Allosteric ModulatorsJeffrey W Schubert, Scott T Harrison, James Mulhearn, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Nature Communications|November 2, 2022
Author Correction: Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland studyClaire E Hastie, David J Lowe, Andrew McAuley, et al.
Nature Communications|October 12, 2022
Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland studyClaire E Hastie, David J Lowe, Andrew McAuley, et al.
Pilot and Feasibility Studies|December 15, 2016
Reducing dementia risk by targeting modifiable risk factors in mid-life: study protocol for the Innovative Midlife Intervention for Dementia Deterrence (In-MINDD) randomised controlled feasibility trialCatherine A O'Donnell, Susan Browne, Maria Pierce, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 19, 2004
Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's diseaseRobert J Ferrante, Hoon Ryu, James K Kubilus, et al.
Chemmedchem|March 29, 2019
Discovery, Optimization, and Biological Characterization of 2,3,6-Trisubstituted Pyridine-Containing M<sub>4</sub> Positive Allosteric ModulatorsJeffrey W Schubert, Scott T Harrison, James Mulhearn, et al.
Pageof 3